share_log

ETRACS 2x Leveraged US Size Factor TR ETN (NYSEARCA:IWML) Trading Down 1.2%

ETRACS 2x Leveraged US Size Factor TR ETN (NYSEARCA:IWML) Trading Down 1.2%

ETRAS 2 倍槓桿式美國規模因數 TR ETN (紐約證券代碼:IWML) 交易指數下跌 1.2%
Defense World ·  2022/12/28 14:11

ETRACS 2x Leveraged US Size Factor TR ETN (NYSEARCA:IWML – Get Rating)'s share price fell 1.2% on Tuesday . The stock traded as low as $14.91 and last traded at $14.91. 30 shares changed hands during trading, a decline of 97% from the average session volume of 1,019 shares. The stock had previously closed at $15.09.

ETRAS 2 倍槓桿美國規模因子 TR ETN(紐西爾證券代碼:IWML — 獲取評級)的股價在周二下跌 1.2%。該股價低至 14.91 美元,最後成交價為 14.91 美元。30 股在交易過程中變手,較 1,019 股平均交易量下跌 97%。該股票之前已收盤 15.09 美元。

ETRACS 2x Leveraged US Size Factor TR ETN Trading Down 1.2 %

ETRAS 2 倍槓桿式美國規模因子 TR ETN 交易所下跌 1.2%

The firm has a 50-day simple moving average of $16.00 and a two-hundred day simple moving average of $15.95.

該公司擁有一個 50 天的簡單移動平均線 16.00 美元和兩百天的簡單移動平均線 15.95 美元。

Further Reading

進一步閱讀

  • Get a free copy of the StockNews.com research report on ETRACS 2x Leveraged US Size Factor TR ETN (IWML)
  • 3 Industrial Stocks to Help Build Your 2023 Watchlist
  • The Institutions Choose CarMax Over Carvana, Should You?
  • Heatmap in Trading: How to Learn What Market Depth Hides
  • Micron Technology Sees Chip Recovery by the End of 2023
  • Three Healthcare Penny Stocks to Watch In The New Year
  • 免費獲取有關 ETRAS 兩倍槓桿美國規模因子 TR ETN(IWML)的研究報告
  • 3 種工業股票可幫助建立您的 2023 觀察列表
  • 機構選擇 CarMax 而不是卡瓦娜,你應該嗎?
  • 交易中的熱圖:如何了解市場深度隱藏了什麼
  • 美光技術將在 2023 年底前恢復芯片
  • 三個醫療保健便士股在新的一年要關注

Receive News & Ratings for ETRACS 2x Leveraged US Size Factor TR ETN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ETRACS 2x Leveraged US Size Factor TR ETN and related companies with MarketBeat.com's FREE daily email newsletter.

每日接收 ETRAS 2 倍槓桿美國規模因子 TR ETN 的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 ETASS 2 倍槓桿美國規模因子 TR ETN 及相關公司的最新新聞和分析師評級的簡要每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論